# Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer

> **NCT01566435** · PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 30 (actual)

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **DRUG:** paclitaxel albumin-stabilized nanoparticle formulation
- **DRUG:** Cisplatin
- **DRUG:** Fluorouracil
- **RADIATION:** Intensity modulated radiation therapy
- **DRUG:** Cetuximab
- **PROCEDURE:** Quality-of-life assessment

## Key facts

- **NCT ID:** NCT01566435
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-09
- **Primary completion:** 2013-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566435, "Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01566435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*